DIALYSIS · CCN 392790

USRC Central York

York, PA 17403

DialysisProfitUS Renal Care, Inc.
$4.8M
TOTAL REVENUE
16.4%
OPERATING MARGIN
2 / 5
STAR RATING
15
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$4.8M
Total costs
$4.0M
Operating income (rev − costs)
$785K
Operating margin
16.4%
Total charges
$4.8M
Total treatments
10,704
Dialysis stations
12

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

15 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
9949—
Percentage of Adult PD Patients with Kt/V >= 1.7
DFC_ADULT_PD_KTV
9229—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.6863—
Fistula Rate
DFC_FISTULA_RATE
47.156—
Five Star Rating
DFC_FIVE_STAR
2——
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
164.782—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
081—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2556—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
19322—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
26.859—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
28.567—
Standardized ED Visits Ratio
DFC_SEDR
0.4246—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
20.435—